Month: January 2024

Asia Pacific Wire & Cable Corporation Limited Reports Third Quarter 2023 Financial Results

Written by Customer Service on January 2, 2024. Posted in Earnings Releases And Operating Results.

TAIPEI, Taiwan, Jan. 02, 2024 (GLOBE NEWSWIRE) — Asia Pacific Wire & Cable Corporation Limited (NASDAQ: APWC) (“APWC” or the “Company”), a leading manufacturer of wire and cable products for the telecommunications and electric-power industries in the Asia-Pacific region, today announced the Company’s financial results for the nine months ended September 30, 2023. Unless otherwise indicated, all data are reported in U.S. Dollars at the exchange rate prevailing on the date of the event or result reported.First Nine Months 2023 Financial Results (Ended September 30, 2023), and 2022 comparative results First 9 Months 2023 First 9 Months 2022 CHANGERevenues $ 294.2 million $ 310.7 million (5.3)%Operating Profit $ 0.1 million $ 3.8 million (97.1)%Net Income $ 1.1 million $ 0.6 million 93.8%EPS1 $ 0.05 $ 0.03 66.7% Revenues...

UNISYNC Reports Fiscal 2023 Financial Results

Written by Customer Service on January 2, 2024. Posted in Earnings Releases And Operating Results.

TORONTO, Jan. 02, 2024 (GLOBE NEWSWIRE) — Unisync Corp. (“Unisync”) (TSX:”UNI”) (OTC:“USYNF”) announces its audited financial results for the fourth quarter and fiscal year ended September 30, 2023. Unisync operates through two business units: Unisync Group Limited (“UGL”) with operations throughout Canada and the USA and 90% owned Peerless Garments LP (“Peerless”), a domestic manufacturing operation based in Winnipeg, Manitoba. UGL is a leading customer-focused provider of corporate apparel, serving many leading Canadian and American iconic brands. Peerless specializes in the production and distribution of highly technical protective garments, military operational clothing, and accessories for a broad spectrum of Federal, Provincial and Municipal government departments and agencies. Results for Fiscal 2023 versus...

Coherus Announces U.S. Launch of LOQTORZI™

Written by Customer Service on January 2, 2024. Posted in Public Companies.

LOQTORZI™ (toripalimab-tpzi)LOQTORZI™ (toripalimab-tpzi) product image– Launch of LOQTORZI offers first and only FDA-approved treatment for NPC in all lines of therapy – – Indicated in combination with chemotherapy for 1st line treatment and as monotherapy for patients with disease progression on or after platinum containing chemotherapy, irrespective of PD-L1 status – – LOQTORZI is now available for purchase through select specialty distributors – REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus,” NASDAQ: CHRS) today announced that LOQTORZI™ (toripalimab-tpzi) is now available through select specialty distributors in the United States. LOQTORZI is indicated in combination with cisplatin and gemcitabine for the first-line treatment of adults with metastatic...

urban-gro, Inc. Secures Design-Build Contract Valued at Approximately $20 Million

Written by Customer Service on January 2, 2024. Posted in Public Companies.

LAFAYETTE, Colo., Jan. 02, 2024 (GLOBE NEWSWIRE) — urban-gro, Inc. (Nasdaq: UGRO) (“urban-gro” or the “Company”), an integrated professional services consulting firm, today announced that it has secured a design-build contract with an existing vertically integrated U.S.-based multi-state Cannabis cultivation and retail dispensary operator. The contract is for the design and construction of both a new cultivation facility and the interior retrofit of an existing facility. The contract is valued at approximately $20 million and it is anticipated that revenue will be recognized over the next six quarters. Bradley Nattrass, Chairman and CEO, commented, “Our turnkey approach coupled with our unique industry expertise allows us to streamline complex projects like this one by seamlessly integrating the design and construction phases....

Spero Therapeutics Announces First Patient, First Visit for Phase 3 PIVOT-PO Trial Evaluating Tebipenem HBr in Complicated Urinary Tract Infections

Written by Customer Service on January 2, 2024. Posted in Public Companies.

$95 million in development milestones payable over two years, as part of GSK license agreement CAMBRIDGE, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, announced today the first patient, first visit for PIVOT-PO, a global pivotal Phase 3 clinical trial of tebipenem HBr in patients with complicated urinary tract infections (cUTI), including acute pyelonephritis (AP). Spero is entitled to receive $95 million in development milestone payments from GSK, which is payable in four equal installments over two years. “First patient visit, in the PIVOT-PO Phase 3 clinical trial, is an...

Branded Legacy, Inc. ($BLEG) Retires Additional 442 Million Common Shares, Surpassing Initial Commitment

Written by Customer Service on January 2, 2024. Posted in Mergers And Acquisitions.

MELBOURNE, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) — via IBN — Branded Legacy (OTC: BLEG) is further highlighting its commitment to shareholders and future growth by announcing the final retirement of an additional 442 million common shares, bringing the total shares retired to an extraordinary 2.44 billion. This action surpasses the initial commitment and signifies management’s unwavering dedication to shareholder value. This development underscores Branded Legacy’s commitment to responsible corporate governance and transparent communication with its investors. Notably, the retirements have resulted in management now owning zero common stock, aligning the company’s leadership with the best interests of its shareholders. The decision to retire an additional 442 million common shares is a testament to Branded Legacy’s...

Watsco Declares $2.45 Quarterly Dividend and Commemorates Paying Dividends for 50 Consecutive Years

Written by Customer Service on January 2, 2024. Posted in Dividend Reports And Estimates.

MIAMI, Jan. 02, 2024 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $2.45 on each outstanding share of its Common and Class B common stock payable on January 31, 2024 to shareholders of record at the close of business on January 17, 2024. Albert H. Nahmad, Watsco’s Chairman and CEO stated: “This marks our 50th consecutive year of paying dividends. We believe this represents an extraordinary milestone, especially given the Company’s strong track record of growth. We are very pleased to share our success with shareholders through dividends, which have grown at a compounded annual growth rate of 21% since Watsco entered distribution in 1989.” The Company’s philosophy is to share cash flow through dividends while maintaining a conservative balance sheet with continued...

Refrigerants Market Size Worth USD 11.75 Billion in 2032 | Emergen Research

Written by Customer Service on January 2, 2024. Posted in Mergers And Acquisitions.

Increasing usage of refrigerants in the pharmaceutical industry is a major factor driving Refrigerants market revenue growth vancouver, Jan. 02, 2024 (GLOBE NEWSWIRE) — The global refrigerants market size was USD 6.30 Billion in 2022 and is expected to register a rapid revenue CAGR of 6.5 % during the forecast period. The global refrigerants market is experiencing significant growth, primarily driven by the increasing usage of refrigerants in the pharmaceutical industry. Refrigerants play a crucial role in maintaining the integrity of medicinal materials, ensuring they remain uncontaminated. Stringent regulatory requirements for the storage of pharmaceutical drugs and vaccines necessitate the use of cold storage refrigerants, ranging from 2°C-8°C, and cool storage refrigerants with temperatures varying from 8°C to 15°C. The adoption...

H World Group Limited Announces the Change of Officers

Written by Customer Service on January 2, 2024. Posted in Public Companies.

SHANGHAI, China, Jan. 02, 2024 (GLOBE NEWSWIRE) — H World Group Limited (NASDAQ: HTHT and HKEX: 1179) (“H World” or the “Company”), a key player in the global hotel industry, today announced that Ms. Jihong He will step down as the chief financial officer of the Company and serve as the chief strategy officer of the Company, effective from January 2, 2024. Mr. Jun Zou, the executive vice president of the Company, has been appointed as the chief financial officer of the Company, effective from the same date. Mr. Zou has over 30 years of experience in financial management and capital markets in the U.S., Europe and China. Prior to joining H World, Mr. Zou worked as the chief financial officer of Shenzhen Qiqitong Technology Co., Ltd., a one-stop digital sourcing management platform. Prior to that, Mr. Zou served as the chief financial...

Kadant Completes Acquisition of Key Knife, Inc.

Written by Customer Service on January 2, 2024. Posted in Mergers And Acquisitions.

WESTFORD, Mass., Jan. 02, 2024 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) has completed its previously announced acquisition of Key Knife, Inc. and certain of its affiliates (“Key Knife”) for approximately $156 million in cash, subject to certain customary adjustments. The acquisition was financed primarily through borrowings under Kadant’s revolving credit facility. Key Knife is a global supplier of engineered knife systems for custom chipping, planing, and flaking solutions for wood product industries. Its products enable wood processing mills to improve fiber recovery, product quality, and maximize production while lowering operating costs. The company is headquartered in Tualatin, Oregon with 141 employees located primarily in the United States and Canada. Key Knife’s revenue for the trailing twelve months ended September...

Month: January 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals